162 related articles for article (PubMed ID: 31541523)
1. Non-canonical Raf-1/p70S6K signalling in non-small-cell lung cancer.
Qiu Z; Ye B; Zhao S; Li X; Li L; Mo X; Li W
J Cell Mol Med; 2019 Nov; 23(11):7632-7640. PubMed ID: 31541523
[TBL] [Abstract][Full Text] [Related]
2. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
3. The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth.
Qiu ZX; Sun RF; Mo XM; Li WM
PLoS One; 2016; 11(1):e0147185. PubMed ID: 26771549
[TBL] [Abstract][Full Text] [Related]
4. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation.
Paleari L; Catassi A; Ciarlo M; Cavalieri Z; Bruzzo C; Servent D; Cesario A; Chessa L; Cilli M; Piccardi F; Granone P; Russo P
Cell Prolif; 2008 Dec; 41(6):936-59. PubMed ID: 19040571
[TBL] [Abstract][Full Text] [Related]
5. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma.
Xu K; Sun G; Li M; Chen H; Zhang Z; Qian X; Li P; Xu L; Huang W; Wang X
Mol Cancer Ther; 2019 Nov; 18(11):2085-2096. PubMed ID: 31341030
[TBL] [Abstract][Full Text] [Related]
7. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
[TBL] [Abstract][Full Text] [Related]
8. The anticancer effects of Cucurbitacin I inhibited cell growth of human non‑small cell lung cancer through PI3K/AKT/p70S6K pathway.
Zhu X; Huang H; Zhang J; Liu H; Ao R; Xiao M; Wu Y
Mol Med Rep; 2018 Feb; 17(2):2750-2756. PubMed ID: 29207097
[TBL] [Abstract][Full Text] [Related]
9. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
[TBL] [Abstract][Full Text] [Related]
10. Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer.
Hsu JL; Leu WJ; Zhong NS; Guh JH
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641511
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic role of CB2 in the progression of non-small-cell lung cancer.
Xu S; Ma H; Bo Y; Shao M
Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
[TBL] [Abstract][Full Text] [Related]
13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
14. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
15. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway.
Sui Y; Yao H; Li S; Jin L; Shi P; Li Z; Wang G; Lin S; Wu Y; Li Y; Huang L; Liu Q; Lin X
J Mol Med (Berl); 2017 Mar; 95(3):311-322. PubMed ID: 27838742
[TBL] [Abstract][Full Text] [Related]
16. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis.
Tang Y; Yan G; Song X; Wu K; Li Z; Yang C; Deng T; Sun Y; Hu X; Yang C; Bai H; Li H; Tan W; Ye M; Liu J
J Cell Mol Med; 2015 Dec; 19(12):2806-17. PubMed ID: 26354852
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
20. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.
Blasco RB; Francoz S; Santamaría D; Cañamero M; Dubus P; Charron J; Baccarini M; Barbacid M
Cancer Cell; 2011 May; 19(5):652-63. PubMed ID: 21514245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
